by Se Young Lee, Hallie Gu | Jan 22, 2020 | Hospitals, News, Pharmaceutical
BEIJING (Reuters) – China reported four more cases of pneumonia believed to be caused by a new coronavirus strain, causing rising concern globally that a disease health officials do not yet fully understand could spread during a key holiday period. The new...
by Carl O'Donnell in New York and Tamara Mathias in Bengaluru; Editing by Tomasz Janowski, Michele Gershberg and Mark Potter | Dec 6, 2019 | Inspiration, News, Pharmaceutical
Reuters – Eleven drugmakers led by Pfizer and Novartis have set aside a combined $2 billion to invest in gene therapy manufacturing since 2018, according to a Reuters analysis, in a drive to better control production of the world’s priciest medicines. FILE...
by Society for Healthcare Epidemiology of America | Nov 5, 2019 | News, Pharmaceutical
Overuse of antibiotics in healthcare contributes to the development of antibiotic-resistant bacteria, resulting in 2 million infections and 100,000 deaths in the U.S. each year, but research is lacking to inform antibiotic stewardship programs aimed at reining in...
by John Miller | Sep 2, 2019 | Pharmaceutical
FILE PHOTO: Logo of Swiss drugmaker Novartis is seen at its branch in Schweizerhalle near Basel, Switzerland, March 29, 2018. REUTERS/Arnd Wiegmann/File Photo ZURICH (Reuters) – Swiss drugmaker Novartis on Friday stepped up its challenge to Roche’s multiple...
by Manojna Maddipatla | Aug 21, 2019 | Pharmaceutical
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland (Reuters) – Roche Holding AG has priced at about $204,560 a year its personalized cancer treatment, Rozlytrek, that targets tumors with specific genetic mutations,...
by No author. | Jun 17, 2019 | Oncology, Pharmaceutical
FILE PHOTO: Brad Zakes (L), founder of Ethan Zakes Foundation/CEO of Cerevast Medical, and Nick Leschly, CEO of bluebird bio at the opening of Swiss pharmaceutical group Lonza’s dedicated cell and gene therapy facility in Houston, Texas, U.S., April 10, 2018....
